Nordics’ pure-play P&C insurer Sampo mulls demerger to reduce market risk
Sampo, the “largest” and most diversified pure-play P&C insurer in the Nordics by premium income, is seeking a partial demerger of the group in a bid to improve its capital efficiency and reduce market risk.
Following a strategic review, the board of directors of Sampo have proposed a partial demerger of the group to separate its wholly-owned financial services subsidiary Mandatum from its property and casualty business.
Management believes the demerger would create a “leading pure-play Nordic P&C insurer capable of delivering high and stable returns on capital”, and offer independence to Mandatum. The demerger process, established in Finland, provides a financially efficient means of delivering the separation in one step, said Björn Wahlroos, chair of the board.
Sampo said its strategic focus is firmly on P&C insurance, but the board sees “limited room” to commit to support this within the current group dynamic.
Sampo’s P&C business is primarily focused on retail clients and SMEs, which accounted for 89% of its total P&C insurance premiums in 2022. The company generated €8 billion in premiums in 2022.
Mandatum has a legacy portfolio of with-profits policies that has been in run-off for over a decade. For the financial years 2020 – 2022, Mandatum returned €500 million of capital to Sampo.
If implemented after the group’s annual general meeting in May, Sampo expects the demerger to generate potential capital efficiency that would drive a reduction in its exposure to market risk through a fall in the group’s exposure to risk assets and with-profit insurance liabilities, supporting a reduction in the volatility of earnings and capital. With reduced exposure to market stress events, Sampo could be able to operate with lower financial buffers.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze